Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antihemophilic Factor Drug Market Size Growth Rate by Type
1.3.2 250 IU
1.3.3 500 IU
1.3.4 1000 IU
1.3.5 1500 IU
1.3.6 2000 IU
1.3.7 3000 IU
1.3.8 4000 IU
1.3.9 Other potencies
1.4 Market Segment by Application
1.4.1 Global Antihemophilic Factor Drug Market Share by Application (2018-2025)
1.4.2 Adult
1.4.3 Pediatric
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antihemophilic Factor Drug Market Size
2.1.1 Global Antihemophilic Factor Drug Revenue 2013-2025
2.1.2 Global Antihemophilic Factor Drug Sales 2013-2025
2.2 Antihemophilic Factor Drug Growth Rate by Regions
2.2.1 Global Antihemophilic Factor Drug Sales by Regions 2013-2018
2.2.2 Global Antihemophilic Factor Drug Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Antihemophilic Factor Drug Sales by Manufacturers
3.1.1 Antihemophilic Factor Drug Sales by Manufacturers 2013-2018
3.1.2 Antihemophilic Factor Drug Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Antihemophilic Factor Drug Revenue by Manufacturers (2013-2018)
3.2.2 Antihemophilic Factor Drug Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Antihemophilic Factor Drug Market Concentration Ratio (CR5 and HHI)
3.3 Antihemophilic Factor Drug Price by Manufacturers
3.4 Key Manufacturers Antihemophilic Factor Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antihemophilic Factor Drug Market
3.6 Key Manufacturers Antihemophilic Factor Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 250 IU Sales and Revenue (2013-2018)
4.1.2 500 IU Sales and Revenue (2013-2018)
4.1.3 1000 IU Sales and Revenue (2013-2018)
4.1.4 1500 IU Sales and Revenue (2013-2018)
4.1.5 2000 IU Sales and Revenue (2013-2018)
4.1.6 3000 IU Sales and Revenue (2013-2018)
4.1.7 4000 IU Sales and Revenue (2013-2018)
4.1.8 Other potencies Sales and Revenue (2013-2018)
4.2 Global Antihemophilic Factor Drug Sales Market Share by Type
4.3 Global Antihemophilic Factor Drug Revenue Market Share by Type
4.4 Antihemophilic Factor Drug Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Antihemophilic Factor Drug Sales by Application
6 North America
6.1 North America Antihemophilic Factor Drug Breakdown Data by Company
6.2 North America Antihemophilic Factor Drug Breakdown Data by Type
6.3 North America Antihemophilic Factor Drug Breakdown Data by Application
6.4 North America Antihemophilic Factor Drug Breakdown Data by Countries
6.4.1 North America Antihemophilic Factor Drug Sales by Countries
6.4.2 North America Antihemophilic Factor Drug Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe Antihemophilic Factor Drug Breakdown Data by Company
7.2 Europe Antihemophilic Factor Drug Breakdown Data by Type
7.3 Europe Antihemophilic Factor Drug Breakdown Data by Application
7.4 Europe Antihemophilic Factor Drug Breakdown Data by Countries
7.4.1 Europe Antihemophilic Factor Drug Sales by Countries
7.4.2 Europe Antihemophilic Factor Drug Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antihemophilic Factor Drug Breakdown Data by Company
8.2 Asia Pacific Antihemophilic Factor Drug Breakdown Data by Type
8.3 Asia Pacific Antihemophilic Factor Drug Breakdown Data by Application
8.4 Asia Pacific Antihemophilic Factor Drug Breakdown Data by Countries
8.4.1 Asia Pacific Antihemophilic Factor Drug Sales by Countries
8.4.2 Asia Pacific Antihemophilic Factor Drug Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam
9 Central & South America
9.1 Central & South America Antihemophilic Factor Drug Breakdown Data by Company
9.2 Central & South America Antihemophilic Factor Drug Breakdown Data by Type
9.3 Central & South America Antihemophilic Factor Drug Breakdown Data by Application
9.4 Central & South America Antihemophilic Factor Drug Breakdown Data by Countries
9.4.1 Central & South America Antihemophilic Factor Drug Sales by Countries
9.4.2 Central & South America Antihemophilic Factor Drug Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Antihemophilic Factor Drug Breakdown Data by Type
10.2 Middle East and Africa Antihemophilic Factor Drug Breakdown Data by Application
10.3 Middle East and Africa Antihemophilic Factor Drug Breakdown Data by Countries
10.3.1 Middle East and Africa Antihemophilic Factor Drug Sales by Countries
10.3.2 Middle East and Africa Antihemophilic Factor Drug Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.1.4 Antihemophilic Factor Drug Product Introduction
11.1.5 Bayer Recent Development
11.2 Shire
11.2.1 Shire Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.2.4 Antihemophilic Factor Drug Product Introduction
11.2.5 Shire Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.3.4 Antihemophilic Factor Drug Product Introduction
11.3.5 Novo Nordisk Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.4.4 Antihemophilic Factor Drug Product Introduction
11.4.5 Pfizer Recent Development
11.5 Grifols
11.5.1 Grifols Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.5.4 Antihemophilic Factor Drug Product Introduction
11.5.5 Grifols Recent Development
11.6 CSL Behring
11.6.1 CSL Behring Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.6.4 Antihemophilic Factor Drug Product Introduction
11.6.5 CSL Behring Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.7.4 Antihemophilic Factor Drug Product Introduction
11.7.5 Sanofi Recent Development
11.8 Cigna
11.8.1 Cigna Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.8.4 Antihemophilic Factor Drug Product Introduction
11.8.5 Cigna Recent Development
11.9 Octapharma
11.9.1 Octapharma Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.9.4 Antihemophilic Factor Drug Product Introduction
11.9.5 Octapharma Recent Development
11.10 GC Pharma
11.10.1 GC Pharma Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.10.4 Antihemophilic Factor Drug Product Introduction
11.10.5 GC Pharma Recent Development
11.11 Hualan Biological Engineering
11.12 Shanghai RAAS blood products
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Antihemophilic Factor Drug Sales Channels
12.2.2 Antihemophilic Factor Drug Distributors
12.3 Antihemophilic Factor Drug Customers
13 Market Forecast
13.1 Global Antihemophilic Factor Drug Sales and Revenue Forecast 2018-2025
13.2 Global Antihemophilic Factor Drug Sales Forecast by Type
13.3 Global Antihemophilic Factor Drug Sales Forecast by Application
13.4 Antihemophilic Factor Drug Forecast by Regions
13.4.1 Global Antihemophilic Factor Drug Sales Forecast by Regions 2018-2025
13.4.2 Global Antihemophilic Factor Drug Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Antihemophilic Factor Drug Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Antihemophilic Factor Drug Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Antihemophilic Factor Drug Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Antihemophilic Factor Drug Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Antihemophilic Factor Drug Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure Antihemophilic Factor Drug Product Picture
Table Antihemophilic Factor Drug Key Market Segments
Table Major Manufacturers Antihemophilic Factor Drug Covered in This Report
Table Global Antihemophilic Factor Drug Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global Antihemophilic Factor Drug Sales Market Shar by Type 2013-2025
Figure 250 IU Figures
Table Major Manufacturers of 250 IU
Figure 500 IU Figures
Table Major Manufacturers of 500 IU
Figure 1000 IU Figures
Table Major Manufacturers of 1000 IU
Figure 1500 IU Figures
Table Major Manufacturers of 1500 IU
Figure 2000 IU Figures
Table Major Manufacturers of 2000 IU
Figure 3000 IU Figures
Table Major Manufacturers of 3000 IU
Figure 4000 IU Figures
Table Major Manufacturers of 4000 IU
Figure Other potencies Figures
Table Major Manufacturers of Other potencies
Table Global Antihemophilic Factor Drug Market Share by Application 2018-2025 (K Units)
Figure Adult Use Case
Figure Pediatric Use Case
Figure Antihemophilic Factor Drug Report Years Considered
Figure Global Antihemophilic Factor Drug Market Size 2013-2025 (Million US$)
Figure Global Antihemophilic Factor Drug Sales 2013-2018 (K Units)
Table Global Antihemophilic Factor Drug Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Antihemophilic Factor Drug Sales by Regions 2013-2018 (K Units)
Table Global Antihemophilic Factor Drug Sales Market Share by Regions 2013-2018
Figure Global Antihemophilic Factor Drug Sales Market Share by Regions 2013-2018
Figure Global Antihemophilic Factor Drug Sales Market Share by Regions in 2018
Table Global Antihemophilic Factor Drug Revenue by Regions 2013-2018 (Million US$)
Table Global Antihemophilic Factor Drug Revenue Market Share by Regions 2013-2018
Figure Global Antihemophilic Factor Drug Revenue Market Share by Regions 2013-2018
Figure Global Antihemophilic Factor Drug Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Antihemophilic Factor Drug Sales by Manufacturers (2013-2018) (K Units)
Table Global Antihemophilic Factor Drug Sales Share by Manufacturers (2013-2018)
Figure Global Antihemophilic Factor Drug Sales Share by Manufacturers in 2018
Table Antihemophilic Factor Drug Revenue by Manufacturers (2013-2018) (Million USD)
Table Antihemophilic Factor Drug Revenue Share by Manufacturers (2013-2018)
Figure Antihemophilic Factor Drug Value Share by Manufacturers in 2018
Table Global Antihemophilic Factor Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Antihemophilic Factor Drug Price (2013-2018) (USD/Unit)
Table Key Manufacturers Antihemophilic Factor Drug Plants/Factories Distribution
Table Key Manufacturers Antihemophilic Factor Drug Area Served
Table Date of Key Manufacturers Enter into Antihemophilic Factor Drug Market
Table Key Manufacturers Antihemophilic Factor Drug Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global 250 IU Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 500 IU Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 1000 IU Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 1500 IU Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 2000 IU Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 3000 IU Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 4000 IU Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Other potencies Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Antihemophilic Factor Drug Sales by Type (2013-2018) (K Units)
Table Global Antihemophilic Factor Drug Sales Share by Type (2013-2018)
Figure Global Antihemophilic Factor Drug Sales Market Share by Type (2013-2018)
Figure Global Antihemophilic Factor Drug Sales Market Share by Type in 2017
Table Global Antihemophilic Factor Drug Revenue by Type (2013-2018) (Million US$)
Table Global Antihemophilic Factor Drug Revenue Share by Type (2013-2018)
Figure Global Antihemophilic Factor Drug Revenue Market Share by Type (2013-2018)
Figure Global Antihemophilic Factor Drug Revenue Market Share by Type in 2017
Table Antihemophilic Factor Drug Price by Type 2013-2018 (USD/Unit)
Table Global Antihemophilic Factor Drug Sales by Application (2013-2018) (K Units)
Table Global Antihemophilic Factor Drug Sales Share by Application (2013-2018)
Figure Global Sales Antihemophilic Factor Drug Market Share by Application (2013-2018)
Figure Global Sales Antihemophilic Factor Drug Market Share by Application in 2017
Figure North America Antihemophilic Factor Drug Sales Growth Rate 2013-2018 (K Units)
Figure North America Antihemophilic Factor Drug Revenue Growth Rate 2013-2018 (Million US$)
Table North America Antihemophilic Factor Drug Sales by Company (2013-2018) (K Units)
Table North America Antihemophilic Factor Drug Sales Market Share by Company (2013-2018)
Figure North America Antihemophilic Factor Drug Sales Market Share by Company in 2018
Table North America Antihemophilic Factor Drug Sales by Type (2013-2018) (K Units)
Table North America Antihemophilic Factor Drug Sales Market Share by Type (2013-2018)
Figure North America Antihemophilic Factor Drug Market Share by Type in 2018
Table North America Antihemophilic Factor Drug Sales by Application (2013-2018) (K Units)
Table North America Antihemophilic Factor Drug Sales Market Share by Application (2013-2018)
Figure North America Antihemophilic Factor Drug Market Share by Application in 2018
Table North America Antihemophilic Factor Drug Sales by Countries (2013-2018) (K Units)
Table North America Antihemophilic Factor Drug Sales Market Share by Countries (2013-2018)
Figure 2017 North America Antihemophilic Factor Drug Sales Market Share by Countries
Table North America Antihemophilic Factor Drug Revenue by Countries (2013-2018) (Million US$)
Table North America Antihemophilic Factor Drug Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Antihemophilic Factor Drug Revenue Market Share by Countries
Figure United States Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Canada Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Europe Antihemophilic Factor Drug Sales Growth Rate 2013-2018 (K Units)
Figure Europe Antihemophilic Factor Drug Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Antihemophilic Factor Drug Sales by Company (2013-2018) (K Units)
Table Europe Antihemophilic Factor Drug Sales Market Share by Company (2013-2018)
Figure Europe Antihemophilic Factor Drug Sales Market Share by Company in 2018
Table Europe Antihemophilic Factor Drug Sales by Type (2013-2018) (K Units)
Table Europe Antihemophilic Factor Drug Sales Market Share by Type (2013-2018)
Figure 2017 Europe Antihemophilic Factor Drug Market Share by Type
Table Europe Antihemophilic Factor Drug Sales by Application (2013-2018) (K Units)
Table Europe Antihemophilic Factor Drug Sales Market Share by Application (2013-2018)
Figure 2017 Europe Antihemophilic Factor Drug Market Share by Application
Table Europe Antihemophilic Factor Drug Sales by Countries (2013-2018) (K Units)
Table Europe Antihemophilic Factor Drug Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Antihemophilic Factor Drug Sales Market Share by Countries
Table Europe Antihemophilic Factor Drug Revenue by Countries (2013-2018) (Million US$)
Table Europe Antihemophilic Factor Drug Revenue Market Share by Countries (2013-2018)
Figure Europe Antihemophilic Factor Drug Revenue Market Share by Countries in 2018
Figure Germany Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure France Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure UK Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Italy Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Russia Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Asia Pacific Antihemophilic Factor Drug Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Antihemophilic Factor Drug Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Antihemophilic Factor Drug Sales by Company (2013-2018) (K Units)
Table Asia Pacific Antihemophilic Factor Drug Sales Market Share by Company (2013-2018)
Figure Asia Pacific Antihemophilic Factor Drug Sales Market Share by Company in 2018
Table Asia Pacific Antihemophilic Factor Drug Sales by Type (2013-2018) (K Units)
Table Asia Pacific Antihemophilic Factor Drug Sales Market Share by Type (2013-2018)
Figure Asia Pacific Antihemophilic Factor Drug Market Share by Type in 2018
Table Asia Pacific Antihemophilic Factor Drug Sales by Application (2013-2018) (K Units)
Table Asia Pacific Antihemophilic Factor Drug Sales Market Share by Application (2013-2018)
Figure Asia Pacific Antihemophilic Factor Drug Market Share by Application in 2018
Table Asia Pacific Antihemophilic Factor Drug Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Antihemophilic Factor Drug Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Antihemophilic Factor Drug Sales Market Share by Countries
Table Asia Pacific Antihemophilic Factor Drug Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Antihemophilic Factor Drug Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Antihemophilic Factor Drug Revenue Market Share by Countries
Figure China Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure China Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Japan Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Korea Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure India Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure India Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Australia Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Central & South America Antihemophilic Factor Drug Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Antihemophilic Factor Drug Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Antihemophilic Factor Drug Sales by Company (2013-2018) (K Units)
Table Central & South America Antihemophilic Factor Drug Sales Market Share by Company (2013-2018)
Figure Central & South America Antihemophilic Factor Drug Sales Market Share by Company in 2018
Table Central & South America Antihemophilic Factor Drug Sales by Type (2013-2018) (K Units)
Table Central & South America Antihemophilic Factor Drug Sales Market Share by Type (2013-2018)
Figure Central & South America Antihemophilic Factor Drug Market Share by Type in 2018
Table Central & South America Antihemophilic Factor Drug Sales by Application (2013-2018) (K Units)
Table Central & South America Antihemophilic Factor Drug Sales Market Share by Application (2013-2018)
Figure Central & South America Antihemophilic Factor Drug Market Share by Application in 2018
Table Central & South America Antihemophilic Factor Drug Sales by Countries (2013-2018) (K Units)
Table Central & South America Antihemophilic Factor Drug Sales Market Share by Countries (2013-2018)
Figure Central & South America Antihemophilic Factor Drug Sales Market Share by Countries in 2018
Table Central & South America Antihemophilic Factor Drug Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Antihemophilic Factor Drug Revenue Market Share by Countries (2013-2018)
Figure Central & South America Antihemophilic Factor Drug Revenue Market Share by Countries in 2018
Figure Brazil Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa Antihemophilic Factor Drug Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Antihemophilic Factor Drug Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Antihemophilic Factor Drug Sales by Type (2013-2018) (K Units)
Table Middle East and Africa Antihemophilic Factor Drug Sales Market Share by Type (2013-2018)
Figure 2017 Middle East and Africa Antihemophilic Factor Drug Market Share by Type
Table Middle East and Africa Antihemophilic Factor Drug Sales by Application (2013-2018) (K Units)
Table Middle East and Africa Antihemophilic Factor Drug Sales Market Share by Application (2013-2018)
Figure 2017 Middle East and Africa Antihemophilic Factor Drug Market Share by Application
Table Middle East and Africa Antihemophilic Factor Drug Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Antihemophilic Factor Drug Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Antihemophilic Factor Drug Sales Market Share by Countries
Table Middle East and Africa Antihemophilic Factor Drug Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Antihemophilic Factor Drug Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Antihemophilic Factor Drug Revenue Market Share by Countries
Figure GCC Countries Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (K Units)
Figure Egypt Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (K Units)
Figure South Africa Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (K Units)
Table Bayer Company Details
Table Bayer Description and Business Overview
Table Bayer Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bayer Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table Bayer Antihemophilic Factor Drug Sales Market Share in Global Market
Table Bayer Recent Development
Table Shire Company Details
Table Shire Description and Business Overview
Table Shire Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Shire Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table Shire Antihemophilic Factor Drug Sales Market Share in Global Market
Table Shire Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Description and Business Overview
Table Novo Nordisk Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Novo Nordisk Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table Novo Nordisk Antihemophilic Factor Drug Sales Market Share in Global Market
Table Novo Nordisk Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Pfizer Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table Pfizer Antihemophilic Factor Drug Sales Market Share in Global Market
Table Pfizer Recent Development
Table Grifols Company Details
Table Grifols Description and Business Overview
Table Grifols Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Grifols Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table Grifols Antihemophilic Factor Drug Sales Market Share in Global Market
Table Grifols Recent Development
Table CSL Behring Company Details
Table CSL Behring Description and Business Overview
Table CSL Behring Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table CSL Behring Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table CSL Behring Antihemophilic Factor Drug Sales Market Share in Global Market
Table CSL Behring Recent Development
Table Sanofi Company Details
Table Sanofi Description and Business Overview
Table Sanofi Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Sanofi Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table Sanofi Antihemophilic Factor Drug Sales Market Share in Global Market
Table Sanofi Recent Development
Table Cigna Company Details
Table Cigna Description and Business Overview
Table Cigna Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Cigna Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table Cigna Antihemophilic Factor Drug Sales Market Share in Global Market
Table Cigna Recent Development
Table Octapharma Company Details
Table Octapharma Description and Business Overview
Table Octapharma Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Octapharma Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table Octapharma Antihemophilic Factor Drug Sales Market Share in Global Market
Table Octapharma Recent Development
Table GC Pharma Company Details
Table GC Pharma Description and Business Overview
Table GC Pharma Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table GC Pharma Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table GC Pharma Antihemophilic Factor Drug Sales Market Share in Global Market
Table GC Pharma Recent Development
Table Hualan Biological Engineering Company Details
Table Shanghai RAAS blood products Company Details
Figure Antihemophilic Factor Drug Value Chain
Table Antihemophilic Factor Drug Distributors List
Table Antihemophilic Factor Drug Customers List
Table Global Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units) & (Million US$)
Figure Global Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Global Antihemophilic Factor Drug Revenue Forecast 2018-2025 (Million US$)
Table Global Antihemophilic Factor Drug Sales Forecast by Type 2018-2025 (K Units)
Figure Global Antihemophilic Factor Drug Sales Forecast by Type 2018-2025 (K Units)
Figure Global Antihemophilic Factor Drug Sales Market Share Forecast by Type 2018-2025
Table Global Antihemophilic Factor Drug Sales Forecast by Application 2018-2025 (K Units)
Figure Global Antihemophilic Factor Drug Sales Forecast by Application 2018-2025 (K Units)
Figure Global Antihemophilic Factor Drug Sales Market Share Forecast by Application 2018-2025
Table Global Antihemophilic Factor Drug Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Antihemophilic Factor Drug Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Antihemophilic Factor Drug Sales Market Share Forecast by Regions 2018-2025
Table Global Antihemophilic Factor Drug Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Antihemophilic Factor Drug Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Antihemophilic Factor Drug Revenue Market Share Forecast by Regions 2018-2025
Table North America Antihemophilic Factor Drug Sales Forecast by Countries 2018-2025 (K Units)
Table North America Antihemophilic Factor Drug Sales Market Share Forecast by Countries 2018-2025
Table North America Antihemophilic Factor Drug Revenue Forecast by Countries 2018-2025 (Million US$)
Table North America Antihemophilic Factor Drug Revenue Market Share Forecast by Countries 2018-2025
Figure United States Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Canada Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure MexicoAntihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Table Europe Antihemophilic Factor Drug Sales Forecast by Countries 2018-2025 (K Units)
Table Europe Antihemophilic Factor Drug Sales Market Share Forecast by Countries 2018-2025
Table Europe Antihemophilic Factor Drug Revenue Forecast by Countries 2018-2025 (Million US$)
Table Europe Antihemophilic Factor Drug Revenue Market Share Forecast by Countries 2018-2025
Figure Germany Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure France Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure UK Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Italy Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Russia Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Table Asia Pacific Antihemophilic Factor Drug Sales Forecast by Countries 2018-2025 (K Units)
Table Asia Pacific Antihemophilic Factor Drug Sales Market Share Forecast by Countries 2018-2025
Table Asia Pacific Antihemophilic Factor Drug Revenue Forecast by Countries 2018-2025 (Million US$)
Table Asia Pacific Antihemophilic Factor Drug Revenue Market Share Forecast by Countries 2018-2025
Figure China Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Japan Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Korea Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure India Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Australia Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Indonesia Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Thailand Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Malaysia Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Philippines Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Vietnam Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Table Central & South America Antihemophilic Factor Drug Sales Forecast by Countries 2018-2025 (K Units)
Table Central & South America Antihemophilic Factor Drug Sales Market Share Forecast by Countries 2018-2025
Table Central & South America Antihemophilic Factor Drug Revenue Forecast by Countries 2018-2025 (Million US$)
Table Central & South America Antihemophilic Factor Drug Revenue Market Share Forecast by Countries 2018-2025
Figure Brazil Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Table Middle East and Africa Antihemophilic Factor Drug Sales Forecast by Regions 2018-2025 (K Units)
Table Middle East and Africa Antihemophilic Factor Drug Sales Market Share Forecast by Regions 2018-2025
Table Middle East and Africa Antihemophilic Factor Drug Revenue Forecast by Regions 2018-2025 (Million US$)
Table Middle East and Africa Antihemophilic Factor Drug Revenue Market Share Forecast by Regions 2018-2025
Figure GCC Countries Antihemophilic Factor Drug Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Antihemophilic Factor Drug Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Antihemophilic Factor Drug Sales Growth Rate (2016-2025) (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
【掲載企業】
Bayer、Shire、Novo Nordisk、Pfizer、Grifols、CSL Behring、Sanofi、Cigna、Octapharma、GC Pharma、Hualan Biological Engineering、Shanghai RAAS blood products